CURATIVE POTENTIAL NOW IN 2L DLBCL

https://global.columvi-hcp.com/?cid=na1191708001&utm_source=medscape&utm_medium=na&utm_campaign=columvi2026&utm_content=tx%3Aagenative%3A2603%3Axx&dclid=CjkKEQjw_9bWBhDiscOaku6CnKkBEiQAKCg80nE2km_tXx8jxv0bSnvbxCJY14soZkwxNvGTx15fUMTw_wcB&gad_source=7&gad_campaignid=23680757487 At 3 years, regardless of your patient’s age or relapse time in 2L DLBCL, COLUMVI + GemOx demonstrates sustained survival benefit. And it’s well tolerated. Be confident with the first and only approved off-the-shelf therapy with curative potential in 2L DLBCL https://www.medscape.com/invitation/viewTracker.do?src=inve&uac=148436CN